Up‐regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer
- Weitere Titel
-
Untersuchung zur Lysophosphatidylcholin Acyltransferase 1 (LPCAT1) Expression beim Mammakarzinom
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Mehrere Sprachen
- Anmerkungen
-
Hamburg, Universität Hamburg, Dissertation, 2021
- Schlagwort
-
Breast--Cancer
Prognosis
- Ereignis
-
Veröffentlichung
- (wo)
-
Hamburg
- (wer)
-
Staats- und Universitätsbibliothek Hamburg Carl von Ossietzky
- (wann)
-
2021
- Urheber
-
von Hassel, Aurelia Sophie
- URN
-
urn:nbn:de:gbv:18-ediss-96495
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:51 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- von Hassel, Aurelia Sophie
- Staats- und Universitätsbibliothek Hamburg Carl von Ossietzky
Entstanden
- 2021
Ähnliche Objekte (12)
SCARA5 Is Overexpressed in Prostate Cancer and Linked to Poor Prognosis
Up-regulation of Biglycan is associated with poor prognosis and PTEN deletionin patients with prostate cancer
The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer
Identification of Plasma Metabolites Associated with Breast and Ovarian Cancer and Breast Cancer Prognosis
Multi-State models for the long-term prognosis of breast cancer
Genetic variation in immunosuppressive pathways and breast cancer susceptibility and prognosis
Quality Assured Health Care in Certified Breast Centers and Improvement of the Prognosis of Breast Cancer Patients
Predictors of poor aesthetic outcome after breast-conserving surgery in patients with breast cancer
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Prognosis
Prognosis
SCARA5 Is Overexpressed in Prostate Cancer and Linked to Poor Prognosis
Up-regulation of Biglycan is associated with poor prognosis and PTEN deletionin patients with prostate cancer
The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer
Identification of Plasma Metabolites Associated with Breast and Ovarian Cancer and Breast Cancer Prognosis
Multi-State models for the long-term prognosis of breast cancer
Genetic variation in immunosuppressive pathways and breast cancer susceptibility and prognosis
Quality Assured Health Care in Certified Breast Centers and Improvement of the Prognosis of Breast Cancer Patients
Predictors of poor aesthetic outcome after breast-conserving surgery in patients with breast cancer
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Prognosis
Prognosis
SCARA5 Is Overexpressed in Prostate Cancer and Linked to Poor Prognosis
Up-regulation of Biglycan is associated with poor prognosis and PTEN deletionin patients with prostate cancer
The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer
Identification of Plasma Metabolites Associated with Breast and Ovarian Cancer and Breast Cancer Prognosis
Multi-State models for the long-term prognosis of breast cancer
Genetic variation in immunosuppressive pathways and breast cancer susceptibility and prognosis
Quality Assured Health Care in Certified Breast Centers and Improvement of the Prognosis of Breast Cancer Patients
Predictors of poor aesthetic outcome after breast-conserving surgery in patients with breast cancer
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Prognosis